Sanofi and AstraZeneca win EU approval for prevention of infant RSV
The long-acting therapy, also known as nirsevimab, was given the European Union (EU) marketing authorisation for the prevention of…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.